Shortened questionnaire on quality of life for inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 10, Issue 4, 2004, Pages 383-391

  Alcala M J ^b   Casellas, Francesc ^b   Fontanet, G ^b   Prieto, L ^a   Malagelada, J R ^b  

^a Spanish Grp Study Methodol Clin ^*  (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Crohn's disease; Health related quality of life; Inflammatory bowel disease; Rasch Analysis; Short questionnaire; Ulcerative colitis

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORRELATION FUNCTION; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELAPSE; RELIABILITY; REMISSION; SCORING SYSTEM; SENSITIVITY ANALYSIS; SPAIN; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS; VALIDATION PROCESS;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HEALTH STATUS; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; SENSITIVITY AND SPECIFICITY;

EID: 3543058841     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200407000-00009     Document Type: Article

References (42)

1. Schipper H, Clinch J, Olweny CLM. Quality of life studies: Definitions and conceptual issues. In: Spilker B, ed. Quality of life and pharmaco-economics in clinical trials. Philadelphia, Lippincott-Raven Press, 1996: 11-23.
2. Yacavone RF, Locke GR, Provenzale DT, et al. Quality of life measurement in gastroenterology: What is available? Am J Gastroenterol. 2001; 96:285-297.
3. Mouzas IA. Quality measurement of quality of life in IBD. Arch Gastroenterohepatol. (issues available online from http://www.geocities.com/gastroyu/dec2001/toc.htm) December 2001; 20 (No 3-4).
4. Mitchell A, Guyatt G, Singer J, et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol. 1988; 10:306-310.
5. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96: 804-810.
6. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol. 1992;14:15-19.
7. Russel MG, Pastoor CJ, Brandon S, et al. Validation of the Dutch translation of the inflammatory bowel disease questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion. 1997;58:282-288.
8. Cheung W, Garratt AM, Russell IT, et al. The UK IBDQ-A British version of the inflammatory bowel disease questionnaire: development and validation. J Clin Epidemiol. 2000;53:297-306.
9. Pallis AG, Vlachonikolis IG, Mouzas IA. Quality of life of Greek patients with inflammatory bowel disease. Digestion. 2001;63:240-246.
10. Hjortswang H, Järnerot G, Curman B, et al. Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 2001;36:77-85.
11. Leong RW, Lee YT, Ching JY, et al. Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the Inflammatory Bowel Disease Questionnaire. Aliment Pharmacol Ther. 2003;17:711-718.
12. Kim WH, Cho YS, Yoo HM, et al. Quality of life in Korean patients with inflammatory bowel disease: ulcerative colitis, Crohn's disease and intestinal Behcet's disease. Int J Colorectal Dis. 1999;14:52-57.
13. López Vivancos J, Casellas F, Badia X. et al. Validation of the Spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease. Digestion. 1999;60:274-280.
14. Irvine EJ, Zhou Q. Thompson AK and the CCRPT investigators. The short inflammatory bowel disease questionnaire: A quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol. 1996;91:1571-1578.
15. Ferry GD. Quality of life in inflammatory bowel disease: background and definitions. J Pediatr Gastroenterol Nutr. 1999;28:S15-S18.
16. Coste J, Guillemin F, Pouchot J, et al. Methodological approaches to shortening composite measurement scales. J Clin Epidemiol. 1997;50: 247-252.
17. Jowert SL, Seal CL, Barton JR, et al. Short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroentereol. 2001 ;96:2921-2928.
18. Prieto L, Alonso J, Lamarca R, et al. Rasch measurement for reducing the items of the Nottingham Health Profile. J Outcome Meas. 1998;2:285-301.
19. Bond TG, Fox CM. eds. Applying the Rasch Model: Fundamental Measurement in the Human Sciences. Lawrence Erlbaum Associates Publishers. Mahwah, New Jersey, 2001, 73-4.
20. Haley SM, McHorney CA, Ware JE Jr. Evaluation of the MOS SF-36 Physical functioning scale (SF-10): I. Unidimensionality and reproducibility of the Rasch item scale. J Clin Epidemiol. 1994;47:671-684.
21. McHoney CA, Haley SM, Ware JE Jr. Evaluation of the MOS SF-36 physical functioning scale (PF-10): II. Comparison of relative precision using Likert and Rasch scoring methods. J Clin Epidemiol. 1997;50:451-461.
22. Hays RD, Morales L, Reise S. Item response theory and health out-comes measurement in the 21 st century. Med Care. 2000;38:S28-S42.
23. Hodgson HJF, Bhatti M. Assessment of disease activity in ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 1995;1:117-143.
24. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial. Br Med J. 1989;298:82-86.
25. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet. 1980;1:514.
26. Olaison G, Sjödahl R, Tagesson C. Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation. Gut. 1990;31:325-328.
27. Wright BD, Linacre JM. A user's guide to BIGSTEPS: Rasch-model computer program, version 2.7.Chicago: MESA Press, 1977.
28. Wright BD, Masters GN. Rating scale analysis. Chicago: MESA Press, 1982.
29. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care. 1989;27:178-189.
30. Bullinger M, Anderson R, Cella D, et al. Developing and evaluating cross-cultural instruments from minimum requirements to optimal models. Quality Life Res. 1994;2:451-459.
31. Streiner DL, Norman GR. Basic concepts. In: Streiner DL, eds. Health measurement scales. A practical guide to their development and use. Oxford: University Press, 1989, 4-9.
32. Alonso J. La medición del estado de salud. En: Martinez F, Antó JM, Castellanos PL, et al. Salud Pública, McGraw-Hill, Interamericana de España. Madrid. SAU, 1998: 341-361.
33. Fraga X, Vergara M, Medina C, et al. Effects of smoking on the presentation and clinical course of inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1997;9:683-687.
34. Barley EA, Quirk FH, Jones PW. Asthma health status measurement in clinical practice: validity of a new short and simple instrument. Respir Med. 1998;92:1207-1214.
35. Higginson IJ, Carr AJ. Using quality of life measures in clinical setting. Br Med J. 2001;322:1297-1300.
36. Tesio L. Measuring behaviors and perceptions: Rasch analysis as a tool for rehabilitation research. J Rehabil Med. 2003;35:105-115.
37. Luquet C, Chau N, Guillemin F, et al. A method for shortening instruments using Rasch model. Validation on a hand functional measure. Rev Epidemiol Sante Publique. 2001;49:273-286.
38. Tesio L, Alpini D, Cesarani A, et al. Short form of the Dizziness Handicap Inventory. Am J Phys Med Rehabil. 1999;78:233-241.
39. Fitzpatrick R, Norquist JM, Dawson J, et al. Rasch scoring of outcomes of total hip replacement. J Clin Epidemiol. 2003;56:68-74.
40. Hays RD, Hadorn D. Responsiveness to change: an aspect of validity, not a separate dimension. Qual Life Res. 1992;1:73-75.
41. Pallis AG, Vlachonikolis IG, Mouzas IA. Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece. Available from: http://biomedcentral.com/1471-230X/2/1. BMC Gastroenterol. 2002;2:1.
42. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press, 1997.